Navigation Links
Drug That 'Tags' Decision-making Areas Of The Brain May Aid

Along with aiding efforts to study addicted smokers, a new drug that attaches only to areas of the brain that have been implicated in nicotine addiction may help studies of people battling other disorders such as Alzheimer’s disease and schizophrenia. Developed by UC Irvine Transdisciplinary Tobacco Use Research Center scientists, the new drug ?Nifrolidine ?is a selective binding agent that identifies specific areas of the brain responsible for decision-making, learning and memory. Lead researcher Jogeshwar Mukherjee, UCI associate professor of psychiatry and human behavior, developed Nifrolidine to measure a subtype of nicotine receptors in the living brain by using an imaging technique, positron emission tomography, more commonly known as PET scans. After proving the drug’s effectiveness, Mukherjee believes the drug will have implications for other conditions, as well.

Study results appear in the January issue of the Journal of Nuclear Medicine. “Nifrolidine is suited to provide reliable, quantitative information of these receptors and may therefore be very useful for future human brain imaging studies of nicotine addiction and other clinical conditions in which these brain regions have been implicated,?Mukherjee said. He found in animal tests that Nifrolidine binds to receptors in the temporal and frontal cortex, areas that are responsible for learning and memory as well as reasoning, planning, problem solving and emotion. According to Mukherjee, patients with Alzheimer’s disease have been known to have a 30 percent to 50 percent loss of these receptors “If there is a gradual loss of these receptors over time, Nifrolidine could be a potential marker for early diagnosis of Alzheimer’s disease,?Mukherjee said. Scientists have known that nicotine’s action on these receptors elicits dopamine in various brain regions implicated in nicotine addiction and other disorders. Nicotine acts b y opening specific membrane proteins, called nicotinic receptors, and changing the electrical properties of the cell. The human brain coordinates billions of neurons to mediate complex behaviors such as an infant learning to recognize his or her parents, a senior citizen learning to play piano, or the process of addiction following repetitive exposure to specific drugs. These behaviors all result from the formation of new connections between individual neurons or modifications of existing connections in the brain. “Imaging of nicotine receptors also gives us the potential to study why some people are more addicted to nicotine than others,?Mukherjee said. Additional information : Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and Evaluation of Nicotine {alpha}4{beta}2 Receptor Radioligand, 5-(3'-18F-Fluoropropyl)-3-(2-(S)-Pyrrolidinylmethoxy)Pyridine, in Rodents and PET in Nonhuman Primate. Journal of Nuclear Medicine. 2005 Jan; 46(1): 130-140.
'"/>

Source:University of California, Irvine


Related biology news :

1. WHO Warns Of Increased Risk Of Vector-borne Diseases In Tsunami-affected Areas
2. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
3. Transport System Smuggles Medicines Into Brain
4. Bird Brains Show How Trial and Error May Contribute to Learning
5. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
6. Wiley announces publication of Databasing the Brain
7. Scientists Propose Sweeping Changes to Naming of Bird Neurosystems to Acknowledge Their True Brainpower
8. Brain-mapping technique aids understanding of sleep, wakefulness
9. Some Brain Cells Change Channels To Fine-tune The Message
10. Brain Scans Reveal How Gene May Boost Schizophrenia Risk
11. Brain-injury rehabilitation depends on acetylcholine circuitry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/3/2017)... LAS VEGAS , Jan. 3, 2017 ... announced the introduction of Onitor Track, an innovative biometric ... and men, showcasing this month at the 2017 Consumer ... . In the U.S., the World ... affect more than two-thirds of adults who are overweight ...
(Date:12/19/2016)... , España y TORONTO , 19 de ... con Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, ... clínicos en varios tipos de tumor en 2017, con múltiples sitios ... ... su clase con objetivo en el factor inhibidor de leucemia (LIF), ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... ... January 21, 2017 , ... Nova Oculus Partners ... a pioneering medical device for the treatment of Age-Related Macular Degeneration. , The ... a global regulatory consultancy that helps companies like ours secure government approvals for ...
(Date:1/20/2017)... ... January 20, 2017 , ... The two newest companies to ... for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, launched by ... at 3624 Market Street. , Vironika is developing a treatment for a chronic ...
(Date:1/19/2017)... Research and Markets has announced the addition of the ... - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to ... ... to reach $15,737 million by 2022 from $6,521 in 2015, growing ... Omic technologies segment accounted for more than half of the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... research and development (R&D), today announced the launch of Data Science ... for the rapidly evolving field of precision medicine. , Data Science ...
Breaking Biology Technology: